Pinoxepin (INN ; developmental code name P-5227; pinoxepin hydrochloride (USAN )) is an antipsychotic of the tricyclic group with a dibenzoxepin ring system which was developed in the 1960s but was never marketed.[1][2][3][4][5] It was found in clinical trials to have effectiveness in the treatment of schizophrenia similar to that of chlorpromazine and thioridazine.[4] The drug has marked sedative effects but causes relatively mild extrapyramidal symptoms.[2][4]
Clinical data | |
---|---|
Other names | Pinoxepine; P-5227 |
Routes of administration | Oral |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C23H27ClN2O2 |
Molar mass | 398.93 g·mol−1 |
3D model (JSmol) |
|
| |
|